Patient-friendly, non-technical summary of research papers

July 2026 Research Update

This report covers research on Kleefstra syndrome published in PubMed in July 2026. For other months, see all research updates.

Last update: August 2, 2026

At a glance

EHMT2 gene link

Reports more clearly linked EHMT2 changes to Kleefstra-like features.

DNA methylation match

Some EHMT2 cases shared a DNA methylation pattern with Kleefstra type 1.

Variant type differences

Both de novo and inherited EHMT2 changes were described.

Genetic cause clarity

This month added support that EHMT2 changes can look like Kleefstra type 1. The reports suggest the biology may differ by the type of EHMT2 change, and they did not add day-to-day outcome predictions.

Overview

This month mainly added clarity about genetic causes of a Kleefstra-like picture. Two reports strengthened the idea that changes in EHMT2 can lead to a neurodevelopmental condition that overlaps Kleefstra syndrome type 1.

A key point was that EHMT2-related cases can look similar on both symptoms and molecular testing. In one group of people with new (de novo) EHMT2 variants, the reported molecular patterns matched Kleefstra syndrome type 1 in several ways. This included a DNA methylation "episignature," which is a characteristic chemical pattern on DNA.

The reports also suggested that the path to a Kleefstra-like outcome may differ depending on the type of genetic change. Lab work in one study suggested some EHMT2 variants make a protein that is present but cannot do its usual enzyme job, and may interfere with the normal protein complex. A separate report described a child with two inherited EHMT2 variants, where RNA testing suggested one gene copy made less transcript and the other caused abnormal splicing.

Overall, these findings mostly help explain why someone can have Kleefstra-like features even when EHMT1 is not changed. The reports did not add information that predicts day-to-day outcomes for an individual child.

Get the monthly update by email

Subscribe here to receive an email when a new monthly Kleefstra syndrome update is published. You can unsubscribe at any time. Your address is used for this only; delivery is handled by MailerLite (privacy policy).

Research topics this month

This month, studies pointed to a clearer message: EHMT2 is not just a nearby biology partner of EHMT1, but can itself be a cause of Kleefstra-like neurodevelopmental conditions. Across a group of patients and a separate single-family report, people with EHMT2 changes had clinical features and molecular patterns that looked similar to Kleefstra syndrome type 1, even though the exact genetic setup differed. This helps explain why some individuals can look like they have Kleefstra syndrome but do not have an EHMT1 change.

In seven patients with new (de novo) EHMT2 variants, the reported molecular findings matched Kleefstra syndrome type 1 in several ways, including DNA methylation patterns (an "episignature," meaning a characteristic chemical pattern on DNA) and gene activity patterns. Laboratory work suggested these EHMT2 variants produced a stable protein that could not do its usual methyltransferase job, and the authors proposed it interferes with the normal protein complex (a dominant-negative effect). A mouse carrying a patient-derived variant showed growth, facial/skull, and behavior differences, which supports the idea that these EHMT2 variants can create a Kleefstra-like outcome through a distinct mechanism.

A separate case report described a boy with two EHMT2 variants (one inherited from each parent), fitting an autosomal recessive pattern. His clinical presentation overlapped strongly with Kleefstra syndrome type 1, and his DNA methylation episignature also overlapped with the Kleefstra syndrome type 1 reference set. RNA testing suggested one variant reduced the amount of transcript from that copy of the gene, while the other led to abnormal splicing, together supporting that reduced EHMT2 function can also lead to a Kleefstra-like condition.

For families, this month mainly adds clarity about genetic explanations for a Kleefstra-like picture. It supports that EHMT2 changes can produce similar developmental and behavioral features to Kleefstra syndrome type 1, and that both de novo single-copy changes and inherited two-copy changes have been reported. This may matter most for genetic testing interpretation and for understanding why different families can have similar symptoms but different gene findings, although these reports do not by themselves predict an individual child's course. What remains uncertain is how often EHMT2 is the cause in people with Kleefstra-like features, and how well specific EHMT2 variant types map to day-to-day outcomes across larger groups.

Limitations

How often EHMT2 explains Kleefstra-like features is still uncertain.
Links between specific EHMT2 variant types and everyday outcomes are not clear.
Some findings came from small numbers and a single-family report.

Important information

This document summarizes recent research from PubMed-indexed publications using automated methods.
It is intended for educational purposes and does not replace medical advice.
Links to the original studies are provided via PubMed, where readers can explore abstracts and, when available, access full-text articles.
Some studies may include additional details that were not accessible for this summary.
Readers seeking more complete detail or context may find it helpful to review the original studies directly.